HBK Investments LP - Form 8.3 - Allergan Plc
PR Newswire
London, October 18
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
- KEYINFORMATION
| Name of person dealing (Note 1) | HBK Investments L.P. on behalf of itself, its subadvisors and its managed funds |
| Company dealt in | ALLERGAN PLC |
| Class of relevant security to which the dealings being disclosed relate (Note 2) | US $0.0001 Ordinary Shares |
| Dateofdealing | 17 October 2019 |
- INTERESTS AND SHORT POSITIONS
- Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Long | Short | |||||
| Number | (%) | Number | (%) | |||
| (1) Relevant securities | 100 (0.00%) | 29,223 (0.00%) | ||||
| (2)Derivatives(otherthanoptions) | 5,900,000 (1.79%) | |||||
| (3) Options and agreements to purchase/sell | 37,200 (0.01%) | 36,000 (0.01%) | ||||
| Total | 5,937,300 (1.80%) | 65,223 (0.01%) | ||||
- Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
| Class of relevant security: | Long | Short | ||||
| Number | (%) | Number | (%) | |||
| (1) Relevant securities | ||||||
(2)Derivatives(otherthanoptions) | ||||||
(3) Options and agreements to purchase/sell | ||||||
| Total | ||||||
Ap20
- DEALINGS (Note 4)
- Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit (Note 5) |
- Derivatives transactions (other than options transactions)
| Product name, e.g.CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
| Total Return Swap | Reducing long position | 50,000 | USD 171.9126 |
- Options transactions in respect of existing relevant securities
- Writing, selling, purchasing or varying
| Product name, e.g.calloption | Writing,selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type,e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
- Exercising
| Product name, e.g.calloption | Number of securities | Exercise price per unit (Note 5) |
- Other dealings (including transactions in respect of new securities) (Note 4)
| Natureoftransaction (Note 8) | Details | Priceperunit (if applicable) (Note 5) |
Ap21
2.OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None.
Is a Supplemental Form 8 attached? (Note 9)YES
| Date of disclosure | 18 October 2019 |
| Contactname | Jonathan Brown |
| Telephonenumber | +44 (0)20 7659 1906 |
| Ifa connected EFM, name of offeree/offeror with which connected | |
| Ifa connected EFM, state nature of connection (Note 10) |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name, e.g.calloption | Written,or purchased | Number of relevant securities to which the option or derivative relates | Exercise price (Note 2) | Type,e.g. American, European etc. | Expiry date |
| Call Option | Purchased | 20,000 | USD 135 | American | 17 Jan 2020 |
| Call Option | Purchased | 17,200 | USD 120 | American | 17 Jan 2020 |
| Put Option | Purchased | 20,000 | USD 130 | American | 17 Jan 2020 |
| Put Option | Purchased | 16,000 | USD 120 | American | 17 Jan 2020 |
Notes
- Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
- For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
